[
  {
    "ts": null,
    "headline": "How The Story For Cardinal Health (CAH) Is Shifting In Analysts Fair Value Views",
    "summary": "What Is Driving the Updated Fair Value Estimate? The slight move in Cardinal Health's fair value estimate, from US$216.60 to US$222.20 per share, reflects how recent research is weighing progress in the business against ongoing risks. On one side, analysts are reacting to stronger views on earnings power tied to specialty growth, the Solaris acquisition, and steadier core Pharma distribution results. On the other side, they are still flagging questions around recovery in the Global Medical...",
    "url": "https://finnhub.io/api/news?id=d793a21a69be2a478fc2ff0c7753a21da310303ed342bf5a0d7053f99489f35f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768133307,
      "headline": "How The Story For Cardinal Health (CAH) Is Shifting In Analysts Fair Value Views",
      "id": 138069372,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "What Is Driving the Updated Fair Value Estimate? The slight move in Cardinal Health's fair value estimate, from US$216.60 to US$222.20 per share, reflects how recent research is weighing progress in the business against ongoing risks. On one side, analysts are reacting to stronger views on earnings power tied to specialty growth, the Solaris acquisition, and steadier core Pharma distribution results. On the other side, they are still flagging questions around recovery in the Global Medical...",
      "url": "https://finnhub.io/api/news?id=d793a21a69be2a478fc2ff0c7753a21da310303ed342bf5a0d7053f99489f35f"
    }
  },
  {
    "ts": null,
    "headline": "Has Cardinal Health (CAH) Run Too Far After A 309% Five Year Share Price Gain?",
    "summary": "If you are wondering whether Cardinal Health's share price still offers value after a strong run, this breakdown will help you frame what the current price could be telling you. The stock recently closed at US$201.11, with returns of 1.5% over the last 30 days, a 2.2% decline year to date, and gains of 67.5% over 1 year, 176.1% over 3 years, and 309.3% over 5 years. Recent coverage around Cardinal Health has largely focused on its role as a major healthcare distributor and its exposure to...",
    "url": "https://finnhub.io/api/news?id=cddf9ce9f2c357d4b765b9ddd24528516c14d83a8a092779a9d3d5664efb4dd6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768126121,
      "headline": "Has Cardinal Health (CAH) Run Too Far After A 309% Five Year Share Price Gain?",
      "id": 138069373,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "If you are wondering whether Cardinal Health's share price still offers value after a strong run, this breakdown will help you frame what the current price could be telling you. The stock recently closed at US$201.11, with returns of 1.5% over the last 30 days, a 2.2% decline year to date, and gains of 67.5% over 1 year, 176.1% over 3 years, and 309.3% over 5 years. Recent coverage around Cardinal Health has largely focused on its role as a major healthcare distributor and its exposure to...",
      "url": "https://finnhub.io/api/news?id=cddf9ce9f2c357d4b765b9ddd24528516c14d83a8a092779a9d3d5664efb4dd6"
    }
  },
  {
    "ts": null,
    "headline": "A Look At Cardinal Health (CAH) Valuation As Momentum Meets Modest Discount To Fair Value",
    "summary": "Cardinal Health (CAH) is drawing fresh attention as investors reassess its recent share performance alongside the company’s scale, with revenue of US$234.3b and net income of US$1.6b from its diversified healthcare operations. See our latest analysis for Cardinal Health. The latest share price of US$201.11 sits alongside a 30.33% 3‑month share price return and a 67.50% 1‑year total shareholder return, which points to strong recent momentum after a weaker year‑to‑date share price return. If...",
    "url": "https://finnhub.io/api/news?id=71d98bf3ff6689f8f2c8f916f8ae36883cbd805c1954d63b04a81229dbba6772",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768111572,
      "headline": "A Look At Cardinal Health (CAH) Valuation As Momentum Meets Modest Discount To Fair Value",
      "id": 138069374,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal Health (CAH) is drawing fresh attention as investors reassess its recent share performance alongside the company’s scale, with revenue of US$234.3b and net income of US$1.6b from its diversified healthcare operations. See our latest analysis for Cardinal Health. The latest share price of US$201.11 sits alongside a 30.33% 3‑month share price return and a 67.50% 1‑year total shareholder return, which points to strong recent momentum after a weaker year‑to‑date share price return. If...",
      "url": "https://finnhub.io/api/news?id=71d98bf3ff6689f8f2c8f916f8ae36883cbd805c1954d63b04a81229dbba6772"
    }
  }
]